Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Sci Rep 6:32206 Zhou L, Zhang H, Davies KJ, Forman HJ (2018) Aging-related decline in the induction of Nrf2-regulated antioxidant genes in human bronchial epithelial cells
Potential future treatments for CKD in type 1 diabetes Beyond the classes of medication discussed above, additional pharmacological treatments are being investigated for use in DKD that may be suitable for use in type 1 diabetes
With tirzepatide, there is now one GIP/GLP-1 receptor dual agonist with a promising development that may find a prominent place in the treatment algorithm for the therapy of T2D and possibly also for obesity
203 ZhuH.SantoA.LiY
When you consider GLP-1 therapy, you notice how patients with obesity must meet specific criteria, such as BMI thresholds, before starting treatment
These growing challenges underscore the urgent need for the development of antifungal agents with novel mechanisms of action, improved specificity, and reduced toxicity, alongside the identification of new molecular targets and therapeutic strategies to mitigate the escalating global burden of fungal diseases
US$ 26.68
.png)
US$ 29.07
US$ 26.97
US$ 21.35
US$ 22.65
US$ 24.89
